Northwestern Medicine scientists have uncovered a neural circuit that drives fear-induced suppression of feeding, according to a study published in Neuron.
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
A new class of drugs shows benefit for both cardiovascular and kidney conditions, but scientists should be cautious in designing trials that include both cardiovascular and kidney outcomes in the same analysis, according to a Northwestern Medicine review article.
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
Reanna Williams, a first-year student in the Physician Assistant program and president of Feinberg’s PA class of 2022, is excited for the ample opportunities becoming a PA can offer her in the healthcare field.
For the first time, Northwestern Medicine scientists have uncovered the complex logic that determines how cochlear cells are connected to the brain during neurodevelopment, according to a recent study.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
Abbey Filicko, a third-year medical student, presented findings from her community-based participatory research project in partnership with Chicago Public Schools at this year’s American Public Health Association (APHA) virtual annual meeting.
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.